🇺🇸 FDA
Patent

US 8784817

Method for killing IL-1 alpha expressing cells

granted A61KA61K2039/55527A61K39/3955

Quick answer

US patent 8784817 (Method for killing IL-1 alpha expressing cells) held by XBIOTECH INC. expires Mon Jul 17 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
XBIOTECH INC.
Grant date
Tue Jul 22 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 17 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
2
CPC classes
A61K, A61K2039/55527, A61K39/3955, A61P, A61P29/00